Skip to content
StockMarketAgent
Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

TYO/3386 stock hub

TYO/3386 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TYO/3386is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
7.2B
Tokyo Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TYO/3386
In the news

Latest news · TYO/3386

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.7P50 15.8P75 21.7
Trailing P/E20.7
P25 11.7P50 15.2P75 22.3
ROE3.6
P25 -1.6P50 7.1P75 11.9
ROIC3.3
P25 -0.6P50 6.2P75 14.3
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TYO/3386 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
223
Groups with data
11
Currency
JPY
Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Japan
Country code
JP
Employees
182
Employees Change
8%
Employees Change Percent
4.6
Enterprise value
JPY 4.5B
Exchange
Tokyo Stock Exchange
Financial currency
JPY
First seen
2026-05-10
Industry
Medical - Diagnostics & Research
Isin
JP3298700000
Last refreshed
2026-05-10
Market cap
JPY 7.2B
Price
JPY 1,264
Price currency
JPY
Rev Per Employee
60,461,538.46x
Sector
Healthcare
Sic
5122
Symbol
tyo/3386
Website
https://www.cosmobio.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
4.84%
EV Earnings
13.08x
EV/EBIT
13.31x
EV/EBITDA
8.8x
EV/Sales
0.41x
P/B ratio
0.71x
P/E ratio
20.68x
P/S ratio
0.65x
PE Ratio10 Y
19.98x
PE Ratio3 Y
19.01x
PE Ratio5 Y
15.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
3.1%
EBITDA Margin
4.69%
Gross margin
34.34%
Gross Profit
JPY 3.8B
Gross Profit Growth
11.2%
Gross Profit Growth Q
12.47%
Gross Profit Growth3 Y
2.47%
Gross Profit Growth5 Y
3.27%
Net Income
JPY 347M
Net Income Growth
28.63%
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Net Income Growth3 Y
-13.29%
Net Income Growth5 Y
-12.94%
Pretax Margin
4.71%
Profit Margin
3.15%
Profit Per Employee
JPY 1.9M
Profitable Years
7
ROA
1.77
Roa5y
3.65
ROCE
3.01
ROE
3.58
Roe5y
5.51
ROIC
3.31
Roic5y
7.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
4.33%
Cagr15y
7.69%
Cagr1y
12.52%
Cagr20y
0.45%
Cagr3y
14.18%
Cagr5y
4.64%
Div CAGR10
12.07%
Div CAGR3
13.72%
Div CAGR5
5.64%
EPS Growth
31.54
EPS Growth Quarters
1
EPS Growth Years
1
EPS Growth3 Y
-12.7
EPS Growth5 Y
-12.22
FCF Growth
1,364%
FCF Growth3 Y
16.92%
FCF Growth5 Y
-13.75%
OCF Growth
146.89%
OCF Growth10 Y
16.52%
OCF Growth3 Y
27.96%
OCF Growth5 Y
-5.82%
Revenue Growth
7.26x
Revenue Growth Q
9.63x
Revenue Growth Quarters
10x
Revenue Growth Years
2x
Revenue Growth3 Y
4.07x
Revenue Growth5 Y
5.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
JPY 0.91
Assets
JPY 12.5B
Cash
JPY 3.2B
Current Assets
JPY 7.4B
Current Liabilities
JPY 1.4B
Debt
JPY 20M
Debt EBITDA
JPY 0.04
Debt Equity
JPY 0
Equity
JPY 10B
Liabilities
JPY 2.5B
Long Term Assets
JPY 5.1B
Long Term Liabilities
JPY 1.1B
Net Cash
JPY 3.2B
Net Cash By Market Cap
JPY 44.93
Net Cash Growth
9.47%
Net Debt EBITDA
JPY -6.25
Net Debt Equity
JPY -0.32
Tangible Book Value
JPY 9.3B
Tangible Book Value Per Share
JPY 1,638
WACC
5.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
6.43
Inventory Turnover
7.33
Net Working Capital
JPY 3.4B
Quick ratio
5.43
Working Capital
JPY 6.6B
Working Capital Turnover
JPY 1.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
2.21%
Dividend Growth
-18.03%
Dividend Growth Years
0%
Dividend per share
JPY 50
Dividend Years
22
Dividend Yield
3.96%
Ex Div Date
2026-06-29
Last Dividend
JPY 25
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
52.78%
1Y total return
12.51%
200-day SMA
1,264.3
3Y total return
48.87%
50-day SMA
1,301.5
50-day SMA vs 200-day SMA
50over200
5Y total return
25.45%
All Time High
7,280
All Time High Change
-82.64%
All Time High Date
2013-06-04
All Time Low
280
All Time Low Change
351.43%
All Time Low Date
2008-10-10
ATR
24.15
Beta
0.18
Beta1y
0.42
Beta2y
0.33
Ch YTD
-3.07
High
1,264
High52
1,486
High52 Date
2025-11-18
High52ch
-14.94%
Low
1,244
Low52
1,083
Low52 Date
2025-11-11
Low52ch
16.71%
Ma50ch
-2.88%
Price vs 200-day SMA
-0.02%
RSI
46.34
RSI Monthly
55.51
RSI Weekly
46.69
Sharpe ratio
0.5x
Sortino ratio
1.39
Total Return
6.17%
Tr YTD
-3.07
Tr15y
203.9%
Tr1m
-0.94%
Tr1w
0.16%
Tr3m
-3.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
JPY 341M
Operating Income Growth
7.52
Operating Income Growth3 Y
-25.12
Operating Income Growth5 Y
-14.55
Operating margin
3.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
3,040,521%
Shares Insiders
8.14%
Shares Institutions
20.31%
Shares Out
5,673,021
Shares Qo Q
-0.02%
Shares Yo Y
-2.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Average Volume
5,010x
Bv Per Share
1,667
Ch10y
16.71
Ch15y
112.8
Ch1m
-0.94
Ch1w
0.16
Ch1y
8.03
Ch20y
-32.94
Ch3m
-3.59
Ch3y
32.36
Ch5y
4.46
Ch6m
13.16
Change
0.72%
Change From Open
1.12
Close
1,255
Days Gap
-0.4
Depreciation Amortization
167,000,000
Dollar Volume
3,286,400
Earnings Date
2026-05-15
EBIT
JPY 341M
EBITDA
JPY 515.8M
EPS
JPY 61.11
F Score
5
Fiscal Year End
December
Founded
1,978
Graham Number
1514.01096
Graham Upside
19.78
Income Tax
JPY 171M
Is Primary Listing
1
Last Earnings Date
2026-02-13
Last Report Date
2025-12-31
Last Split Date
2012-12-26
Last Split Type
Forward
Lynch Fair Value
JPY 306
Lynch Upside
-75.82
Ma150
1,289.6
Ma150ch
-1.99%
Ma20
1,273.3
Ma20ch
-0.73%
Next Earnings Date
2026-05-15
Open
1,250
Payment Date
2026-09-10
Position In Range
100
Ppne
862,000,000
Price Date
2026-05-08
Price EBITDA
JPY 13.9
Ptbv Ratio
0.77
Relative Volume
0.52x
Revenue
11,004,000,000x
Tax By Revenue
1.55x
Tax Rate
33.01%
Tr20y
9.42%
Tr6m
15.31%
Volume
2,600
Z Score
3.95
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TYO/3386 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+4.0%
$50.0 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.6%
0 consecutive years of growth
Total shareholder yield
+6.2%
Next ex-dividend date: 2026-06-29
Performance

TYO/3386 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+12.5%
S&P 500 1Y: n/a
3Y total return
+48.9%
S&P 500 3Y: n/a
5Y total return
+25.5%
S&P 500 5Y: n/a
10Y total return
+52.8%
S&P 500 10Y: n/a
Ownership

Who owns TYO/3386?

Insider, institutional, and short-interest positioning.

Institutional ownership
+20.3%
Share of float held by funds and institutions
Insider ownership
+8.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-2.2%
Negative means the company is buying back shares.
Technical

TYO/3386 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.3
Neutral momentum band
Price vs 200-day MA
-0.0%
50/200-day relationship not available
Beta (5Y)
0.18
Less volatile than the market
Sharpe ratio
0.50
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TYO/3386

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tyo/3386 stock rating?

tyo/3386 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tyo/3386 analysis?

The full report lives at /stocks/tyo/3386/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tyo/3386?

The latest report frames tyo/3386 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tyo/3386 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.